United Therapeutics Chairperson, CEO Martine Rothblatt disposes of 9,500 common shares for $5.01 million - UTHR News | RalliesUnited Therapeutics Chairperson, CEO Martine Rothblatt disposes of 9,500 common shares for $5.01 million
U
UTHR• United Therapeutics insider transaction
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised 9,500 stock options at USD 135.42 on Aug. 19, 2026.
- The trust sold 9,500 shares the same day across multiple trades at about USD 522.49 to USD 535.22.
- Trust holdings ended at 324,443 shares following the transactions, according to the filing.
SPY
•
